Developments include acceptance of 12 Australian patents, issuance of 5 Canadian patents and 3 patents in the United States Filament’s industry-leading global IP portfolio contains 46 allowed patents relating to… Read More
VANCOUVER, BC & BOSTON, MA – Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, announced the appointment of… Read More
PatientView survey is an annual global study that gives patient advocacy groups an opportunity to comment on, and assess, the pharma industry’s performance KIRKLAND, QC – Pfizer is proud to… Read More
Stryker (NYSE: SYK) announced that it entered into a definitive agreement to acquire Care.ai. Care.ai specializes in AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions. Stryker officials believe… Read More
TORONTO, ON – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives… Read More
